Clover Health Investments Corp (CLOV)
🔔 Watch stock
Appears in These Scanners
This stock currently matches 16 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Quality & Screener
AI Rating
Uses AIClover Health ist im Kern ein Medicare-Advantage-Versicherer (ein einziges berichtspflichtiges Segment: Insurance); die hauseigene KI-/Machine-Learning-Software „Clover Assistant" dient nachweislich dem operativen Kostenmanagement (Steuerung der Medizinkostenquote), ist aber keine belegte eigenständige Umsatzquelle. Die externe SaaS-Vermarktung als „Counterpart Assistant" wird in den Risikofaktoren ausdrücklich als noch nicht erfolgreicher „launch" beschrieben — daher „nutzt", nicht „verkauft".
View the full file — quotes, sources, reviewed filings
„Our proprietary software platform, Clover Assistant (licensed externally as Counterpart Assistant), supports clinical real-time decision making at the point of care by equipping the clinical with data and insights."
Unsere firmeneigene Softwareplattform Clover Assistant (extern lizenziert als Counterpart Assistant) unterstützt die klinische Echtzeit-Entscheidungsfindung am Behandlungsort, indem sie das klinische Personal mit Daten und Erkenntnissen ausstattet.
„...generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the most relevant, personalized information about each patient to his or her provider."
... erzeugt auf Behandler ausgerichtete Erkenntnisse aus maschinellem Lernen, künstlicher Intelligenz und Regelwerken und stößt Handlungen an, indem sie die relevantesten, personalisierten Informationen zu jedem Patienten an dessen Behandler ausspielt.
„Our launch of Counterpart Assistant as a Software-as-a-Service (“SaaS”) product for external payors and providers serving the Medicare eligible population may not be successful, and, as a result, our business may be adversely affected."
Unsere Markteinführung von Counterpart Assistant als Software-as-a-Service-Produkt („SaaS") für externe Kostenträger und Leistungserbringer, die die Medicare-berechtigte Bevölkerung versorgen, könnte scheitern, und infolgedessen könnte unser Geschäft beeinträchtigt werden.
Filings Reviewed: 10-K 2026-02-27 · 10-Q 2026-05-08 · 10-Q 2025-11-07 · 10-Q 2025-08-08 · 10-Q 2025-05-09 · 10-K 2025-03-03
Rated on July 10, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.04 | – | 337 | -34.00 | -6.60 | -86 | -86 |
| 2025: Q1 | 0.00 | – | 462 | 33.30 | -0.30 | -16 | -17 |
| 2025: Q2 | -0.02 | -238.90 | 478 | 34.10 | -2.20 | 5 | 5 |
| 2025: Q3 | -0.05 | – | 497 | 50.10 | -4.90 | 12 | 11 |
| 2025: Q4 | -0.10 | – | 488 | 44.70 | -10.10 | -68 | -69 |
| 2026: Q1 | 0.05 | – | 749 | 62.00 | 3.60 | 108 | 107 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Clover Health Investments, Corp. bietet Medicare-Advantage-Pläne in den USA an.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 724 |
| Headquarters | Wilmington, DE |
| Website | cloverhealth.com |
| IPO Date | 2. Jan 2001 |
| Next Earnings | 4. Aug 2026 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Vivek Garipalli | Co-Founder & Executive Chairman | 1979 |
| Andrew Toy | Co-Founder, CEO & Director | 1979 |
| Brady Priest J.D. | CEO of Clover Care Services | 1976 |
| Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage | 1969 |
| Conrad Wai | CEO of Counterpart Health | 1981 |
| Clay Thornton | Interim Chief Financial Officer | 1990 |
| Joseph Frank Oldakowski | VP of Finance, Controller & Principal Accounting Officer | 1983 |
| Wendy Richey | Chief Compliance Officer | – |
| Karen Soares | Chief Legal Officer, General Counsel, Senior VP & Corporate Secretary | 1978 |
| Rachel Fish | Chief People Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.